BDATCOs Business Development Business evolution is at the tit of our growth strategy; one of our main objectives is to acquire or in-license products in late-stage development or in the market. Our aim is to chassis strong relationships and maintain partner-of-choice status in the fields of gastroenterology and cystic fibrosis. Over the years, we have developed a reputation as a top-tier partner in a very combative marketplace. Our knowledge in the GI space and our high-performing gross sales force, in both North America and Europe, have allowed us to increase the value of acquired and/or in-licensed products, resulting in progressively higher sales and earnings year after year. The BD Team would appreciate each contact Via: Business Development B-18 SITE. Karachi. 75700, We offer... * Strong reputation in Derma, Cardio, CNS, Paeds, Anti-malarial & international ampere; Anti-viral. * Success-oriented scientific marketing and Local distribution network passim Pakistan. * History of successful product launches. * Development and manufacturing capabilities. * Strong regulatory expertise and know-how in Pakistan. * Fast internal decision-making procedures. * Security and flexibleness of being a privately held independent company. We seek...
* Exclusive distribution, trade collaborations & in-licensing opportunities for new & innovative products. * Marketed or late-stage development products with significant efficacy data * Products or companies with sustainable competitive advantages that lead across unmet medical needs. * Examples of successful cooperations: PIRIBEDIL (CLARIUM®) LICENSED FROM SERVIER (FR) * Non-ergoline dopamine agonist * Indicated for Parkinsons disease (mono therapy, add-on, aboriginal and late stage patients) BOTULINUM TOXIN A (XEOMIN®) LICENSED FROM MERZ (DK, NO, SE)  * Indicated for the characteristic treatment of blepharospasm and cervical dystonia of a predominantly rotational... If you want to get a full essay, order it on our website:
Ordercustompaper.comIf you want to get a full essay, wisit our page:
write my paper
No comments:
Post a Comment